- Advertising
- Asia
- Bangladesh
- Biological Inventions
- BRAND VALUATION
- China
- Comparative Advertisement
- Copyright
- Copyright Infringement
- Copyright Litigation
- Counterfeiting
- Covid
- Data Protection
- Design
- Digital Marketing Rights
- DRM
- Electronics
- Geographical Indication
- India
- Indian Patents Act
- Indonesia
- Intellectual Property
- Interim Injunction
- IP Commercialization
- IP Licensing
- IP Litigation
- IP Practice in India
- IPAB
- IPAB Decisions
- Japan
- Legal Issues
- Licensing
- Malaysia
- Myanmar
- NCLT
- NEPAL
- Net Neutrality
- News & Updates
- Office
- Patent Commercialisation
- Patent Cooperation Treaty
- patent infringement
- Patent Licensing
- Patent Litigation
- Patent Opposition
- Patent Prosecution
- Patent Rule Amendment
- Patent Term Extension
- Patents
- pharma
- Philippines
- Punitive Damages
- Section 3(D)
- section 64
- Singapore
- South-east Asia
- Technology
- Technology Transfer
- Thailand
- Trademark
- Trademark Litigation
- UAE
- Uncategorized
- USPTO
- Vietnam
- WIPO
CRISPR Patent Process And Its Applicability In The Covid Era
INTRODUCTION CRISPR technology is a targeted technique that allows researchers to modify genomes with unprecedented precision, efficiency, and flexibility. This technology is at the heart of a true biotechnology revolution, with huge implications for health, agriculture, and a variety of other sectors. On October 7, 2020, Professors Emmanuelle Charpentier and Jennifer Doudna were awarded the … Continue reading CRISPR Patent Process And Its Applicability In The Covid Era
Read more »IP Waiver and Covid-19 Vaccines
Since 2019, coronavirus hit the whole world and it is now for 2 years, we are facing this unfortunate pandemic. As of 27 October 2021, there is a total of 24.43cr cases and 49.61lakh deaths worldwide with the USA on top followed by India and Brazil. The figures are alarming but the ground situation is … Continue reading IP Waiver and Covid-19 Vaccines
Read more »Zooming Out On Compulsory Licensing Of Covid-19 Vaccines
The unnerving bio- catastrophe, the COVID-19 pandemic has brought an array of challenges for mankind. The COVID-19 scare at the global level is posing threat to human life and the governments are deeply divided over an effort to endorse a temporary patent waiver on COVID-19 vaccines and grant of compulsory licenses. What is Compulsory Licensing? … Continue reading Zooming Out On Compulsory Licensing Of Covid-19 Vaccines
Read more »Compulsory Licensing in India Amidst the COVID 19 Pandemic: Will India Consider it?
The COVID-19 pandemic has truly exposed the frailty of our infrastructural systems. Innovation has taken a front seat and the world is keenly awaiting the public distribution of COVID-19 vaccines which would help restore normalcy. Among the numerous factors that were taken into consideration by global experts with respect to the COVID 19 vaccines, accessibility … Continue reading Compulsory Licensing in India Amidst the COVID 19 Pandemic: Will India Consider it?
Read more »Premas Biotech and Oravax enter into licensing deal for commercialization of VLP injectable vaccine technology in India
Recently, Oravax Medical Inc., (“Oravax” has entered into a licensing agreement with Premas Biotech to make available for commercialization of Oravax’s virus-like particle (VLP) vaccine technology. Oravax is a joint venture between Oramed Pharmaceuticals Inc., a US-based company (the majority shareholder), and Gurugram, India-based life sciences company, Premas Biotech (“Premas”). While the terms of the … Continue reading Premas Biotech and Oravax enter into licensing deal for commercialization of VLP injectable vaccine technology in India
Read more »Patents and Public Health
Introduction Patents and public health is the most relevant topic of discussion when the whole world is fighting against the global pandemic, Covid-19. It is no doubt that granting patent protection to a drug is important and serves many purposes, but can we put the lives of millions of people at stake in this time … Continue reading Patents and Public Health
Read more »Covid-19 & Competition Act Of India
About Competition What does one understand by the word “Competition”? In common man’s language competition in the market would refer to rivalry between 2 entities selling similar products and/or services with the goal of achieving revenue, profit and market share. Thus it ensures that the entities involved with similar products compete on merits and not … Continue reading Covid-19 & Competition Act Of India
Read more »Voluntary Licensing Agreements for Remdesivir
Gliead is rapidly working to fight with this outbreak of novel COVID-19. Remdesivir is a potential drug for the treatment for COVID-19. Remdesivir has formally not been approved as treatment of COVID-19. USA is using appropriate authorities for the investigation of the drug. That there are multiple clinical trials going on check safety and efficiency … Continue reading Voluntary Licensing Agreements for Remdesivir
Read more »Covid-19 And IBC: Unfolding The Loopholes In The Recent Amendments
In the past four months, Covid-19 is the primary reason for economic instability and uncertainty for business and companies globally, Indian companies are no exception. There is no legislation in India that is left unaffected. The government has taken measures to curb the problems in order to handle the unforeseen problems that every sector of … Continue reading Covid-19 And IBC: Unfolding The Loopholes In The Recent Amendments
Read more »